Trastuzumab Deruxtecan 100 mg in India: Advanced Therapy for HER2-Positive Cancers

Health7 months ago

Source: Trastuzumab Deruxtecan 100 mg in India: Advanced Therapy for HER2-Positive Cancers

Trastuzumab Deruxtecan 100 mg is a revolutionary targeted therapy used to treat HER2-positive breast cancer and other HER2-expressing malignancies. This antibody-drug conjugate improves survival rates by delivering chemotherapy directly to cancer cells, reducing damage to healthy tissue. Trastuzumab Deruxtecan 100 mg in India is gaining widespread availability, offering new hope to patients resistant to standard treatments.